Because PMDs deal with sore throats , back pain, paperwork, pain management and don’t understand cardiology and lipidology with notable exceptions of course.
JL Maybe RIT should have been presented at some primary care conference and not at the AHA.
Maybe the study should have been run by a primary care doc and not an international cardiologist.
JLM you are incorrect here. And no they cannot market and promote Vascepa for face lifts. That is off label square use.
JT admitted this very same conclusion yesterday in his presentation. All cardiologists 100 percent should be covered.
Shadolone. Eventually PCP's will be prescribing way more V than Cardiologists, just like more PCP's prescribe statins than cardiologists. That is just a function of there being so many more PCP's than cardiologists and many are on statins for primary prevention and have never seen a cardiologist. So, I understand AMRN's outreach to PCP's but I don't agree with it.
I think CardiologyMD is correct that we should be concentrating on the Cardiologists first since they have the greatest percentage of eligible patients and will be the early adopters. The prescribing will then spread naturally to PCP's as they will see their patients coming back from their cardiology visits on V and begin to change their own prescribing habits as they see specialist adoption.
Market Data 
Markets 
AI
